Jeffrey Cleland is the Chairman, CEO, and President of Ashvattha Therapeutics, a company he co-founded. With a Ph. D. from MIT, he has over 30 years of experience in the biotech industry, specializing in nanomedicine and successfully raising over $500 million in capital throughout his career.
Outside of his professional work, Jeffrey is dedicated to his community and family. He founded and previously chaired the Nativity School Development Fund to manage fundraising for the school and has publicly shared his pride in his daughters accomplishments and work in helping others.
He led one of the most successful biotech IPOs of all time based on valuation, demand, and total proceeds.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.